These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 38849372
1. In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infections. Ajmal A, Shahab M, Waqas M, Zheng G, Zulfat M, Bin Jardan YA, Wondmie GF, Bourhia M, Ali I. Sci Rep; 2024 Jun 07; 14(1):13130. PubMed ID: 38849372 [Abstract] [Full Text] [Related]
2. Repurposing of therapeutic antibodies against dengue virus envelope protein receptor binding domain. Chaudhuri D, Majumder S, Datta J, Giri K. Arch Microbiol; 2024 Jun 20; 206(7):312. PubMed ID: 38900285 [Abstract] [Full Text] [Related]
3. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Panya A, Sawasdee N, Junking M, Srisawat C, Choowongkomon K, Yenchitsomanus PT. Chem Biol Drug Des; 2015 Nov 20; 86(5):1093-104. PubMed ID: 25891143 [Abstract] [Full Text] [Related]
4. Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study. Khan RA, Hossain R, Siyadatpanah A, Al-Khafaji K, Khalipha ABR, Dey D, Asha UH, Biswas P, Saikat ASM, Chenari HA, Wilairatana P, Islam MT. Molecules; 2021 Nov 11; 26(22):. PubMed ID: 34833913 [Abstract] [Full Text] [Related]
5. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus. Anasir MI, Ramanathan B, Poh CL. Viruses; 2020 Mar 26; 12(4):. PubMed ID: 32225021 [Abstract] [Full Text] [Related]
6. Peptide inhibitors against dengue virus infection. Panya A, Bangphoomi K, Choowongkomon K, Yenchitsomanus PT. Chem Biol Drug Des; 2014 Aug 26; 84(2):148-57. PubMed ID: 24612829 [Abstract] [Full Text] [Related]
7. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach. Aarthy M, Singh SK. Curr Top Med Chem; 2018 Aug 26; 18(18):1585-1602. PubMed ID: 30360716 [Abstract] [Full Text] [Related]
8. Anti-dengue virus activity of scytovirin and evaluation of point mutation effects by molecular dynamics and binding free energy calculations. Siqueira AS, Jerônimo Lima AR, de Souza RC, Santos AS, da Silva Gonçalves Vianez Júnior JL, Gonçalves EC. Biochem Biophys Res Commun; 2017 Aug 26; 490(3):1033-1038. PubMed ID: 28666874 [Abstract] [Full Text] [Related]
9. Screening of commercial cyclic peptides as inhibitor envelope protein dengue virus (DENV) through molecular docking and molecular dynamics. Parikesit AA, Kinanty, Tambunan US. Pak J Biol Sci; 2013 Dec 15; 16(24):1836-48. PubMed ID: 24516999 [Abstract] [Full Text] [Related]
10. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein. Amir-Hassan A, Lee VS, Baharuddin A, Othman S, Xu Y, Huang M, Yusof R, Rahman NA, Othman R. J Mol Graph Model; 2017 Jun 15; 74():273-287. PubMed ID: 28458006 [Abstract] [Full Text] [Related]
11. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side. Lin KH, Ali A, Rusere L, Soumana DI, Kurt Yilmaz N, Schiffer CA. J Virol; 2017 May 15; 91(10):. PubMed ID: 28298600 [Abstract] [Full Text] [Related]
12. Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease. Purohit P, Barik D, Dansana J, Meher BR. Comput Biol Chem; 2024 Feb 15; 108():108005. PubMed ID: 38157660 [Abstract] [Full Text] [Related]
13. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity. Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y. Bioorg Med Chem Lett; 2017 Aug 01; 27(15):3586-3590. PubMed ID: 28539222 [Abstract] [Full Text] [Related]
14. An in-silico receptor-pharmacophore based multistep molecular docking and simulation study to evaluate the inhibitory potentials against NS1 of DENV-2. Roy A, Paul I, Paul T, Hazarika K, Dihidar A, Ray S. J Biomol Struct Dyn; 2024 Aug 01; 42(12):6136-6164. PubMed ID: 37517062 [Abstract] [Full Text] [Related]
15. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication. Abdul Ahmad SA, Palanisamy UD, Tejo BA, Chew MF, Tham HW, Syed Hassan S. Virol J; 2017 Nov 21; 14(1):229. PubMed ID: 29162124 [Abstract] [Full Text] [Related]
16. PD1 CD44 antiviral peptide as an inhibitor of the protein-protein interaction in dengue virus invasion. Recalde-Reyes DP, Rodríguez-Salazar CA, Castaño-Osorio JC, Giraldo MI. Peptides; 2022 Jul 21; 153():170797. PubMed ID: 35378215 [Abstract] [Full Text] [Related]
17. Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence. Piccirillo E, Merget B, Sotriffer CA, do Amaral AT. J Comput Aided Mol Des; 2016 Mar 21; 30(3):251-70. PubMed ID: 26923377 [Abstract] [Full Text] [Related]
18. Molecular Characterization and Identification of Potential Inhibitors for 'E' Protein of Dengue Virus. Racherla RG, Katari SK, Mohan A, Amineni U, Badur M, Chaudhury A, Nagaraja M, Kodavala S, Kante M, Kalawat U. Viruses; 2022 Apr 29; 14(5):. PubMed ID: 35632682 [Abstract] [Full Text] [Related]
19. Detection of Dengue Virus-Specific IgM and IgG Antibodies through Peptide Sequences of Envelope and NS1 Proteins for Serological Identification. Nagar PK, Savargaonkar D, Anvikar AR. J Immunol Res; 2020 Apr 29; 2020():1820325. PubMed ID: 32832567 [Abstract] [Full Text] [Related]
20. Peptide inhibitors of dengue virus and West Nile virus infectivity. Hrobowski YM, Garry RF, Michael SF. Virol J; 2005 Jun 01; 2():49. PubMed ID: 15927084 [Abstract] [Full Text] [Related] Page: [Next] [New Search]